Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check4 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedSite maintenance updates include Revision: v3.4.2 and the removal of a prior funding notice (v3.4.1), which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedA government funding notice about NIH Clinical Center operations was added, including status guidance and a link to opm.gov, and a new revision tag v3.4.1 appears while the previous v3.4.0 tag is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page now includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' field, and a 'No FEAR Act Data' note, plus an updated revision label to v3.4.0. The previous 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' entries have been removed or replaced.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. This is a minor metadata update rather than a change to study data or text.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded a dedicated Locations section with Minnesota (Rochester, MN) as the study site and removed the HHS Vulnerability Disclosure footer link; page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.